Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
The Biochemical Journal|April 17, 2015
Structural determinants of human proton-coupled folate transporter oligomerization: role of GXXXG motifs and identification of oligomeric interfaces at transmembrane domains 3 and 6Mike R Wilson, Sita Kugel, Jenny Huang, et al.
Pediatric Blood & Cancer|July 5, 2007
Association between prenatal pesticide exposures and the generation of leukemia-associated T(8;21)Katherine M Lafiura, Dawn M Bielawski, Norberto C Posecion, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2019
Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseasesBarbara Frigerio, Claudia Bizzoni, Gerrit Jansen, et al.
Cancer Medicine|February 15, 2019
Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillanceBatoul Farran, Samet Albayrak, Judith Abrams, et al.
The Journal of Biological Chemistry|December 20, 2011
Identification and functional impact of homo-oligomers of the human proton-coupled folate transporterZhanjun Hou, Sita Kugel Desmoulin, Erika Etnyre, et al.
Molecular Pharmacology|February 4, 2016
Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl AntifolatesMike R Wilson, Zhanjun Hou, Si Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology GroupYubin Ge, Christina L Haska, Katherine LaFiura, et al.
Molecular Pharmacology|June 29, 2012
Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporterSita Kugel Desmoulin, Lei Wang, Lisa Polin, et al.
Cancer Research|January 28, 2004
The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell linesYubin Ge, Tanya L Jensen, Mark L Stout, et al.
Cancer Chemotherapy and Pharmacology|February 16, 2013
Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporterChristina Cherian, Sita Kugel Desmoulin, Lei Wang, et al.
Pageof 13